Detail akcie INNO-GENE online

Business Summary: Hyenergy SA, formerly Inno-Gene SA, is a Poland-based holding company engaged in management of a portfolio of companies active in life-science sector through the technology, research and development. Inno-Gene SA’s portfolio comprises of Centrum Badan DNA Sp. z o.o., a company that provides services in the field of genetic medical diagnostics, including microbiological diagnosis of infection and the suitability of human congenital diseases using tests performed on DNA microarray technology. On March 22, 2013, the Company established a new subsidiary, Centrum Edukacji Bio-Medycznej Sp. z o.o. On April 11, 2013, the Company established two new indirect subsidiaries, Genomix Sp. z o.o. and Madgenetix Sp. z o.o. In addition, it operates through VitainSillica Sp z o o.
Financial Summary: BRIEF: For the three months ended 31 March 2025, Hyenergy SA revenues decreased 16% to PLN71K. Net loss decreased 61% to PLN96K. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Salaries decrease of 78% to PLN53K (expense), Social Securities and Other Fees decrease of 76% to PLN9K (expense).